Inventprise President & CEO Yves Leurquin Attends 2nd Global Forum on Childhood Pneumonia
Yves Leurquin shared the vision and mission of Inventprise’s efforts in developing a high valency pneumococcal conjugate vaccine to provide broader coverage during the 2nd Global Forum on Childhood Pneumonia on April 27, 2023 in Madrid, Spain.
Watch the complete presentation: “The Pipeline of Next-Generation Pneumococcal Vaccines: Who will get access?”
